Alligator Bioscience Ab Stock Debt To Equity
| ATORX Stock | SEK 0.53 0.02 3.64% |
Alligator Bioscience AB fundamentals help investors to digest information that contributes to Alligator Bioscience's financial success or failures. It also enables traders to predict the movement of Alligator Stock. The fundamental analysis module provides a way to measure Alligator Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alligator Bioscience stock.
Alligator |
Alligator Bioscience AB Company Debt To Equity Analysis
Alligator Bioscience's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Alligator Bioscience Debt To Equity | 5.10 % |
Most of Alligator Bioscience's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alligator Bioscience AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Alligator Bioscience AB has a Debt To Equity of 5.1%. This is 90.47% lower than that of the Biotechnology sector and 73.66% lower than that of the Health Care industry. The debt to equity for all Sweden stocks is 89.53% higher than that of the company.
Alligator Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alligator Bioscience's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alligator Bioscience could also be used in its relative valuation, which is a method of valuing Alligator Bioscience by comparing valuation metrics of similar companies.Alligator Bioscience is currently under evaluation in debt to equity category among its peers.
Alligator Fundamentals
| Return On Equity | -1.04 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (5.39) % | |||
| Current Valuation | 236.82 M | |||
| Shares Outstanding | 220.58 M | |||
| Shares Owned By Insiders | 51.92 % | |||
| Shares Owned By Institutions | 11.58 % | |||
| Price To Book | 2.57 X | |||
| Price To Sales | 17.76 X | |||
| Revenue | 12.94 M | |||
| Gross Profit | (111.72 M) | |||
| EBITDA | (130.36 M) | |||
| Net Income | (141.74 M) | |||
| Cash And Equivalents | 278.15 M | |||
| Cash Per Share | 4.27 X | |||
| Total Debt | 3.51 M | |||
| Debt To Equity | 5.10 % | |||
| Current Ratio | 9.65 X | |||
| Book Value Per Share | 0.40 X | |||
| Cash Flow From Operations | (127.03 M) | |||
| Earnings Per Share | (0.60) X | |||
| Target Price | 3.77 | |||
| Number Of Employees | 53 | |||
| Beta | 1.12 | |||
| Market Capitalization | 431.05 M | |||
| Total Asset | 333.2 M | |||
| Z Score | 73.2 | |||
| Net Asset | 333.2 M |
About Alligator Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alligator Bioscience AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alligator Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alligator Bioscience AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.